Ultime prove

EudraCT Number: 2004-003798-94

Sponsor Protocol Number: ASM981A2308

Start Date: 2004-12-10

Sponsor Name: Novartis Pharma Services AG

Full Title: A randomized, open-label, parallel-group study to investigate blood concentrations, safety and tolerability of 2 ointment formulations of ASM981 in adult patients with atopic dermatitis treated top...

Medical condition: Atopic dermatitis (atopic eczema)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: View results

EudraCT Number: 2004-002539-25

Sponsor Protocol Number: ATOM 019

Start Date: 2004-12-10

Sponsor Name: UNIVERSITA' DEGLI STUDI DI UDINE

Full Title: Randomized phase II trial of second-line chemotherapy with oxaliplatin and docetaxel vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC)

Medical condition: Second-line chemotherapy in advanced non small cell lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10059515		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000499-41

Sponsor Protocol Number: 1051/04

Start Date: 2004-12-10

Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Full Title: mechanisms of endothelial disfunction in patients with les: role of TNF- Alpha

Medical condition: Lupus (SLE)

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10021428		SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-002980-26

Sponsor Protocol Number: CACZ885A2102

Start Date: 2004-12-10

Sponsor Name: Novartis Pharma Services AG

Full Title: An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP...

Medical condition: Muckle-Wells Syndrome: rare hereditary, autosomal dominant, systemic inflammatory disease, characterized by recurrent episodes of fever, arthralgia, myalgia, urticarial rash, and conjunctivitis. La...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed) ES (Completed) FR (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2004-002882-19

Sponsor Protocol Number: MCHT001

Start Date: 2004-12-10

Sponsor Name: Mid Cheshire Hospitals NHS Trust

Full Title: A controlled trial into the benefit of topical perianal glyceryl trinitrate (GTN) as a sphincter relaxant, pre-insertion of ultrasound probe for trans rectal ultrasound (TRUS) guided biopsy of the ...

Medical condition: Prostate Cancer Diagnosis – Pain relief during biopsy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2004-002693-37

Sponsor Protocol Number: CD-2

Start Date: 2004-12-10

Sponsor Name: Therakos

Full Title: A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEX IN THE TREATMENT OF PATIENTS WITH MODERATELY ACTIVE CROHN’S DISEASE WHO ARE REFRACTORY OR INTOLERANT TO IMMUNOSUPP...

Medical condition: Patients with Moderately Active Crohn’s Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10011401		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2005-003577-24

Sponsor Protocol Number: 1018

Start Date: 2004-12-10

Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Full Title: remifentanil in continuos infusion as a labour analgesic

Medical condition: analgesia in partum

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10059204		PT

Population Age: Adults

Gender: Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003701-24

Sponsor Protocol Number: 21011

Start Date: 2004-12-10

Sponsor Name: E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER

Full Title: A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.

Medical condition: CUTANEOUS T CELL LYMPHOMA.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-003728-36

Sponsor Protocol Number: 21012

Start Date: 2004-12-10

Sponsor Name: E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER

Full Title: PHASE II CLINICAL TRIAL WITH CAELYX MONO-CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES STAGE IIb, IVa AND IVb WITH OR WITHOUT PREVIOUS CHEMOTHERAPY.

Medical condition: ADVANCED STAGE CUTANEOUS T CELL LYMPHOMA.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-004404-21

Sponsor Protocol Number: SLE-Omega

Start Date: 2004-12-10

Sponsor Name: GreenPark Healthcare Trust [...] 1. GreenPark Healthcare Trust 2. Queens University Belfast

Full Title: Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences

Medical condition: Systemic Lupus Erythematosus

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

Ultime prove

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici